MAPT and Alzheimer disease: Alzheimer’s disease (AD), initially characterized by Alois Alzheimer in 1907 [1], is pathologically marked by two defined events: the deposition of amyloid beta peptide (Aβ) in the intercellular space and the formation of intraneuronal tangles due to hyperphosphorylation of the axonal Tau protein [2].